Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mario Mancino"'
Autor:
Coline H M van Moorsel, Ana Montes-Worboys, Razq Hakem, E. Ellen Billett, Carmen Herranz, Eline Blommaert, Oscar Yanes, Antonio Roman, Julio Ancochea, Álvaro Casanova, Raúl Rigo-Bonnin, Harilaos Filippakis, Berta Saez, August Vidal, Alexandra Baiges, Antoni Xaubet, Suzanne Miller, Antonio Gomez, Roderic Espín, Joanne J van der Vis, José A Rodríguez-Portal, Chiara Gorrini, Jaume Bordas, Marian J R Quanjel, Aleix Noguera-Castells, Luis Palomero, Eva Revilla-López, Josep M. Cruzado, Xiaohu Zhang, Enrique Lastra, Nadia García, Elżbieta Radzikowska, Marc Ferrer, Simon R. Johnson, Christophe Bontoux, Maria Molina-Molina, Alexandra Junza, Javier A. Menendez, Ana I. Extremera, Piedad Ussetti, Rosalía Laporta, Álvaro Lahiguera, Miquel Angel Pujana, Susana Gómez-Ollés, Daniel Cuadras, Mario Mancino, Claudia Valenzuela, Tamara Alonso, Jose C. Perales, Francesca Mateo, Francesc Viñals, Aslihan Ugun-Klusek, Gorka Ruiz de Garibay, Roser Guiteras, Jordi Capellades, Concettina La Motta, Carlos Machahua
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
EMBO Molecular Medicine
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Scientia
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
Dipòsit Digital de la UB
Universidad de Barcelona
EMBO Molecular Medicine, Vol 13, Iss 9, Pp n/a-n/a (2021)
instname
EMBO Molecular Medicine
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Scientia
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
Dipòsit Digital de la UB
Universidad de Barcelona
EMBO Molecular Medicine, Vol 13, Iss 9, Pp n/a-n/a (2021)
Inhibition of mTOR is the standard of care for lymphangioleiomyomatosis (LAM). However, this therapy has variable tolerability and some patients show progressive decline of lung function despite treatment. LAM diagnosis and monitoring can also be cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3528695e98889a787bd38a10b1b3e32
http://hdl.handle.net/10261/265901
http://hdl.handle.net/10261/265901
Autor:
Patricia Jauregui, Aleix Noguera-Castells, Raul Alonso, Silvia Menendez, Laia Serrano, Elisabet Ametller, Ana Lluch, L. Alex Gaither, Federico Rojo, Paloma Bragado, Pere Gascón, Leire Recalde-Percaz, Mario Mancino, Ana Rovira, Estel Enreig, Núria Moragas, Joan Albanell, Patricia Fernández-Nogueira, Vanessa Almendro, Anke Bill, Gemma Fuster, Anna López-Plana
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Purpose:Despite the therapeutic success of existing HER2-targeted therapies, tumors invariably relapse. This study aimed at identifying new mechanisms responsible for HER2-targeted therapy resistance.Experimental Design:We have used a platform of HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e227e565ba327bbbd44f395147ae2e89
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4333
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4333
Autor:
Aleix Noguera-Castells, Elisabet Megías-Roda, Gemma Fuster, Anna López-Plana, Tatiana Erazo, Pau Muñoz-Guardiola, Héctor Pérez-Montoyo, Carles Domenech, Patricia Fernández-Nogueira, Jose Alfon, Pere Gascón, Paloma Bragado, Marc Yeste-Velasco, Leire Recalde-Percaz, Teresa Moran, Ernest Nadal, Mariana Gomez-Ferreria, Patricia Jauregui, Mario Mancino, Jose M. Lizcano, Elisabet Ametller, Sonia Solé-Sánchez, Núria Moragas‐Garcia
Publikováno v:
International journal of cancerReferences. 147(4)
Around 40% of newly diagnosed lung cancer patients are Stage IV, where the improvement of survival and reduction of disease-related adverse events is the main goal for oncologists. In this scenario, we present preclinical evidence supporting the use
Autor:
Miquel Prats de Puig, Paloma Bragado, Patricia Fernández-Nogueira, F J Casado, Neus Carbó, Gemma Fuster, Mario Mancino, Pere Gascón
Publikováno v:
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
E-Prints Complutense. Archivo Institucional de la UCM
instname
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3, p 776 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad Complutense de Madrid
E-Prints Complutense. Archivo Institucional de la UCM
instname
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3, p 776 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Current evidences state clear that both normal development of breast tissue as well as its malignant progression need many-sided local and systemic communications between epithelial cells and stromal components. During development, the stroma, throug
Autor:
Núria Moragas, Pedro Gascon, Arantzazu Zubeldia-Plazaola, Mario Mancino, Gemma Fuster, Flavia Guzman, Aleix Noguera, Miquel Prats de Puig, Paloma Bragado, Leire Recalde-Percaz
Publikováno v:
Cancer Research. 78:80-80
The most accepted theory in breast cancer evolution is the linear progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC). DCIS is defined by a clonal proliferation of epithelial cells that accumulate within the lumen of a
Autor:
Núria Moragas, Gemma Fuster, Mario Mancino, Pedro Gascon, Patricia Fernández-Nogueira, Aleix Noguera-Castells, Leire Recalde-Percaz
Publikováno v:
Cancer Research. 78:2138-2138
Breast cancer (BC) is thought to arise from the linear evolution of begins ductal carcinoma in situ (DCIS) to the invasive ductal carcinoma (IDC). DCIS is a poorly understood disease. Diagnosis of DCIS is increasing in the last few years. All DCIS ar
Autor:
Patricia Jauregui Jimenez, Aleix Noguera Castells, Paloma Bragado Domingo, Gemma Fuster Orellana, Nuria Moragas Garcia, Patricia Fernández-Nogueira, Leire Recalde Percaz, Mario Mancino, Pedro Gascon Villaplana, Maria Neus Carbó Carbó, Anna Lopez Plana
Publikováno v:
Cancer Research. 78:5213-5213
Histamine receptor 1 (HRH1) belongs to the rhodopsin-like G-protein-coupled receptor family. Its activation by histamine, a ubiquitous messenger molecule released mostly from mast cells, has been demonstrated to be involved in cell proliferation, emb
Autor:
Raffaele Palaia, Nicola Normanno, Mario Mancino, Giuseppe D'Aiuto, David S. Salomon, Kazuhide Watanabe, Francesco Perrone, Shin Hamada, Gabriela A. Balogh, Daniel Mailo, Luigi Strizzi, Brenda Jones, Aasia O. Rehman, Gerardo Botti, Jose Russo, Antonella De Luca, Caterina Bianco
Publikováno v:
Clinical Cancer Research. 12:5158-5164
Purpose: Human Cripto-1 (CR-1), a cell membrane glycosylphosphatidylinositol-anchored glycoprotein that can also be cleaved from the membrane, is expressed at high levels in several different types of human tumors. We evaluated whether CR-1 is presen
Autor:
Mario Mancino
Publikováno v:
Cancer Research. 76:5007-5007
The nervous system is now recognized to be a relevant component of the tumor microenvironment. Receptors for neuropeptides and neurotransmitters have been identified in breast cancer. However, very little is known about the role of neurogenes in regu
Autor:
Mario Mancino, Gemma Fuster, Paloma Bragado, Raul Alonso, Patricia Fernández-Nogueira, Pere Gascón
Publikováno v:
European Journal of Cancer. 61:S76